Annual SG&A
$39.06 M
+$16.65 M+74.29%
31 December 2023
Summary:
Terns Pharmaceuticals annual selling, general & administrative expenses is currently $39.06 million, with the most recent change of +$16.65 million (+74.29%) on 31 December 2023. During the last 3 years, it has risen by +$30.07 million (+334.20%). TERN annual SG&A is now at all-time high.TERN Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$9.77 M
+$2.58 M+35.98%
30 September 2024
Summary:
Terns Pharmaceuticals quarterly selling, general & administrative expenses is currently $9.77 million, with the most recent change of +$2.58 million (+35.98%) on 30 September 2024. Over the past year, it has dropped by -$8.58 million (-46.77%). TERN quarterly SG&A is now -46.77% below its all-time high of $18.35 million, reached on 30 September 2023.TERN Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.47 B
-$88.07 M-6.40%
30 September 2024
Summary:
Terns Pharmaceuticals TTM selling, general & administrative expenses is currently -$1.47 billion, with the most recent change of -$88.07 million (-6.40%) on 30 September 2024. Over the past year, it has dropped by -$1.50 billion (-3892.32%). TERN TTM SG&A is now -1494.84% below its all-time high of $39.06 million, reached on 31 December 2023.TERN TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TERN Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +74.3% | -46.8% | -3892.3% |
| 3 y3 years | +334.2% | +107.2% | -9782.4% |
| 5 y5 years | +901.3% | - | - |
TERN Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +334.2% | -46.8% | +107.2% | -143.8% | at low |
| 5 y | 5 years | at high | +901.3% | -46.8% | +879.0% | -1494.8% | at low |
| alltime | all time | at high | +901.3% | -46.8% | +879.0% | -1494.8% | at low |
Terns Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $9.77 M(+36.0%) | $30.41 M(-22.0%) |
| June 2024 | - | $7.18 M(+4.8%) | $39.00 M(+0.5%) |
| Mar 2024 | - | $6.86 M(+3.9%) | $38.82 M(-0.6%) |
| Dec 2023 | $39.06 M(+74.3%) | $6.60 M(-64.0%) | $39.06 M(+1.1%) |
| Sept 2023 | - | $18.35 M(+161.9%) | $38.63 M(+52.0%) |
| June 2023 | - | $7.01 M(-1.3%) | $25.41 M(+6.7%) |
| Mar 2023 | - | $7.10 M(+15.1%) | $23.82 M(+6.3%) |
| Dec 2022 | $22.41 M | $6.17 M(+20.2%) | $22.41 M(+3.5%) |
| Sept 2022 | - | $5.13 M(-5.4%) | $21.66 M(+2.0%) |
| June 2022 | - | $5.42 M(-4.7%) | $21.24 M(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $5.69 M(+5.0%) | $20.68 M(+5.8%) |
| Dec 2021 | $19.55 M(+117.3%) | $5.42 M(+14.9%) | $19.55 M(+29.2%) |
| Sept 2021 | - | $4.71 M(-2.9%) | $15.13 M(+10.1%) |
| June 2021 | - | $4.86 M(+6.5%) | $13.75 M(+20.8%) |
| Mar 2021 | - | $4.56 M(+357.0%) | $11.38 M(+26.5%) |
| Dec 2020 | $9.00 M(+3.8%) | $998.00 K(-70.1%) | $9.00 M(-13.4%) |
| Sept 2020 | - | $3.33 M(+34.1%) | $10.39 M(+47.3%) |
| June 2020 | - | $2.49 M(+14.1%) | $7.05 M(+54.4%) |
| Mar 2020 | - | $2.18 M(-8.8%) | $4.57 M(+91.2%) |
| Dec 2019 | $8.66 M(+122.1%) | $2.39 M | $2.39 M |
| Dec 2018 | $3.90 M | - | - |
FAQ
- What is Terns Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals annual SG&A year-on-year change?
- What is Terns Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals quarterly SG&A year-on-year change?
- What is Terns Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals TTM SG&A year-on-year change?
What is Terns Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of TERN is $39.06 M
What is the all time high annual SG&A for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high annual selling, general & administrative expenses is $39.06 M
What is Terns Pharmaceuticals annual SG&A year-on-year change?
Over the past year, TERN annual selling, general & administrative expenses has changed by +$16.65 M (+74.29%)
What is Terns Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of TERN is $9.77 M
What is the all time high quarterly SG&A for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $18.35 M
What is Terns Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, TERN quarterly selling, general & administrative expenses has changed by -$8.58 M (-46.77%)
What is Terns Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of TERN is -$1.47 B
What is the all time high TTM SG&A for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high TTM selling, general & administrative expenses is $39.06 M
What is Terns Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, TERN TTM selling, general & administrative expenses has changed by -$1.50 B (-3892.32%)